Living with mucopolysaccharidosis, or caring for someone who has it, means navigating a condition that looks different depending on which enzyme is missing, how much residual activity remains, and which organs absorb the most damage over time.

A bone metastasis diagnosis leaves most people trapped between two conversations that never quite connect: the imaging appointment that shows what is there, and the symptom conversation about pain management.

Living with achondroplasia — or supporting someone who does — often means navigating a healthcare system that reacts to complications as they arise rather than anticipating them at a molecular level. Most appointments address what went wrong: foramen magnum narrowing, sleep apnea episodes, spinal stenosis progression.

Living with diastrophic dysplasia — or caring for someone who does — means navigating a condition that most clinicians know only in outline. The genetics are well-characterized in academic literature, but the practical, actionable guidance for optimizing bone and joint health, tracking meaningful markers, and making informed decisions about supplementation and monitoring rarely comes together in one place.

If you've been told you have cervical myelopathy — or you're watching early signs of it in a parent, a partner, or yourself — you've probably noticed that most of the advice out there stops at the same place: "see a spine specialist," "avoid neck strain," "consider surgery if it progresses." None of that is wrong.